Response to the letter to the editor: The role of baseline hepatic function in interpreting adverse events Among patients With hepatocellular carcinoma
Journal of Oncology Pharmacy Practice · 14.11.2026
DOI: 10.1177/10781552261506712 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 14.11.2026. Verfasst von Mathieu Boulin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service Pharmacie, Université de Bourgogne Europe, CHU Dijon Bourgogne, INSERM CTM U1231 EPICAD Dijon, France.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Service Pharmacie, Université de Bourgogne Europe, CHU Dijon Bourgogne, INSERM CTM U1231 EPICAD Dijon, France.
- Service Pharmacie, CHU Dijon Bourgogne, Dijon, France.
- Service d'Hépatogastroenterologie et d'Oncologie Digestive, Université de Bourgogne Europe, CHU Dijon Bourgogne, INSERM CTM U1231 EPICAD Dijon, France.
- Service d'Hépatogastroenterologie et d'Oncologie Digestive, CHU Dijon Bourgogne Dijon, France.
ORCID-Profile: Mathieu Boulin, Pauline Pistre
Zitieren
APA
Boulin, M., Bellini, M., Burlet, S., Fevre, T., Albert, M., Pistre, P., Lepage, C., Latournerie, M., & Manfredi, S. (2026). Response to the letter to the editor: The role of baseline hepatic function in interpreting adverse events Among patients With hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261506712
Vancouver
Boulin M, Bellini M, Burlet S, Fevre T, Albert M, Pistre P, et al. Response to the letter to the editor: The role of baseline hepatic function in interpreting adverse events Among patients With hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261506712
BibTeX
@article{Boulin2026,
author = {Boulin, Mathieu and Bellini, Marion and Burlet, Steven and Fevre, Théoline and Albert, Mélanie and Pistre, Pauline and Lepage, Côme and Latournerie, Marianne and Manfredi, Sylvain},
title = {Response to the letter to the editor: The role of baseline hepatic function in interpreting adverse events Among patients With hepatocellular carcinoma},
journal = {Journal of Oncology Pharmacy Practice},
year = {2026},
doi = {10.1177/10781552261506712}
}
EUVIMED